Status:
UNKNOWN
Surgical Pre-habilitation in Breast Cancer.
Lead Sponsor:
Instituto Nacional de Cancer, Brazil
Conditions:
Breast Neoplasm
Eligibility:
FEMALE
18-80 years
Phase:
NA
Brief Summary
The National Cancer Institute estimated 625 thousand new cases of cancer (excluding cases of non-melanoma skin cancer) in Brazil for each year between 2020-2022. In 2018, there were 2.1 million new ca...
Detailed Description
INTRODUCTION The National Cancer Institute estimated 625 thousand new cases of cancer (excluding non-melanoma skin cancer cases) in Brazil for each year between 2020-2022, In 2018, 2.1 million new cas...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- \- have a diagnosis of breast cancer and indication for cancer treatment with a curative therapeutic proposal
- Exclusion criteria:
- having a previous cancer diagnosis
- staging IV
- practitioner of physical exercise at least 90 minutes per week
- not being able to answer the questionnaires
- be unable to practice unsupervised exercises for any reason, including: dysfunctionss orthopedic, neurological, decompensated cardiorespiratory and severe renal.
Exclusion
Key Trial Info
Start Date :
January 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2023
Estimated Enrollment :
248 Patients enrolled
Trial Details
Trial ID
NCT04861220
Start Date
January 1 2022
End Date
December 30 2023
Last Update
June 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Instituto Nacional do Câncer / HCIII
Rio de Janeiro, Brazil, 20560121